Acetaminophen/Ibuprofen Injection-Reference-Cited by-同舟云学术

Acetaminophen/Ibuprofen Injection

Published:2024-03-05 Issue:4 Volume:59 Page:385-393
ISSN:0018-5787
Container-title:Hospital Pharmacy
language:en
Short-container-title:Hosp Pharm

Author:

Levien Terri L.¹^ORCID,Baker Danial E.¹^ORCID

Affiliation:

1. Washington State University, Spokane, WA, USA

Abstract

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.

Publisher

SAGE Publications

Link

https://journals.sagepub.com/doi/pdf/10.1177/00185787241236439

Reference10 articles.

1. Combogesic IV (Acetaminophen/ibuprofen). Prescribing information. AFT Pharmaceuticals Ltd; October 2023.

2. Combogesic (Acetaminophen/ibuprofen). Prescribing information. AFT Pharmaceuticals Ltd; March 2023.

3. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Food and Drug Administration. Updated November 2023. Accessed November 26, 2023. http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm

4. Acetaminophen injection. Prescribing information. Fresenius Kabi; September 2021.

5. Caldolor (Ibuprofen). Prescribing information. Cumberland Pharmaceuticals Inc; May 2023.